Question 1

Does Goldman Sachs Group own RYTM stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs Group holds 2,126,502 shares of RYTM (Rhythm Pharmaceuticals), worth $236.1M.

Question 2

How many shares of RYTM does Goldman Sachs Group own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs Group holds 2,126,502 shares of RYTM (Rhythm Pharmaceuticals).

Question 3

What is Goldman Sachs Group's RYTM position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs Group's RYTM position is worth $236.1M.

Question 4

Is Goldman Sachs Group buying or selling RYTM?

Accepted Answer

In Q2 2026, Goldman Sachs Group increased its RYTM position by 161,070 shares (+8.2%).

Question 5

When did Goldman Sachs Group first buy RYTM?

Accepted Answer

Goldman Sachs Group already held RYTM in its Q2 2022 13F, the earliest on record, and has listed it in 17 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	2.1M	+8.2%	$236.1M	0.0%	$111.03	33
2026-Q1	Increased	2M	+7.3%	$170.9M	0.0%	$86.97	33
2025-Q4	Decreased	1.8M	-3.3%	$196M	0.0%	$107.04	0
2025-Q3	Increased	1.9M	+9.2%	$191.2M	0.0%	$100.99	33
2025-Q2	Increased	1.7M	+5.8%	$109.6M	0.0%	$63.19	32
2025-Q1	Decreased	1.6M	-9.6%	$86.8M	0.0%	$52.97	0
2024-Q4	Decreased	1.8M	-53.3%	$101.4M	0.0%	$55.98	0
2024-Q3	Decreased	3.9M	-26.6%	$203.3M	0.0%	$52.39	0